Correlation Between Salesforce and Rasna Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Salesforce and Rasna Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Rasna Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Rasna Therapeutics, you can compare the effects of market volatilities on Salesforce and Rasna Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Rasna Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Rasna Therapeutics.

Diversification Opportunities for Salesforce and Rasna Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Salesforce and Rasna is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Rasna Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rasna Therapeutics and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Rasna Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rasna Therapeutics has no effect on the direction of Salesforce i.e., Salesforce and Rasna Therapeutics go up and down completely randomly.

Pair Corralation between Salesforce and Rasna Therapeutics

Considering the 90-day investment horizon Salesforce is expected to generate 16.47 times less return on investment than Rasna Therapeutics. But when comparing it to its historical volatility, Salesforce is 26.8 times less risky than Rasna Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Rasna Therapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  0.61  in Rasna Therapeutics on August 29, 2024 and sell it today you would lose (0.21) from holding Rasna Therapeutics or give up 34.43% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

Salesforce  vs.  Rasna Therapeutics

 Performance 
       Timeline  
Salesforce 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Salesforce are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Salesforce displayed solid returns over the last few months and may actually be approaching a breakup point.
Rasna Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rasna Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Rasna Therapeutics is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Salesforce and Rasna Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Salesforce and Rasna Therapeutics

The main advantage of trading using opposite Salesforce and Rasna Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Rasna Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rasna Therapeutics will offset losses from the drop in Rasna Therapeutics' long position.
The idea behind Salesforce and Rasna Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes